We are live on ! Find out more
HFCIV

H&F Corporate Investors VIII Portfolio holdings

AUM $133M
1-Year Est. Return 24.42%
This Fund
S&P 500
This Quarter Est. Return
+17.62%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
–
AUM
$286M
AUM Growth
+$42.8M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTEV
1
Claritev Corp
CTEV
$652M
$286M 100%
5,387,858
– –

Similar funds

NCTC
New Covenant Trust Company Jeffersonville, Indiana $133M AUM 28.4% 1-Year Est. Return
CWM
Centrica Wealth Management Miami, Florida $133M AUM
FFP
Frisco Financial Planning Frisco, Texas $133M AUM 14.5% 1-Year Est. Return
SI
Severin Investments St. Louis, Missouri $133M AUM 45.69% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
RHIG
R.H. Investment Group Scottsdale, Arizona $133M AUM 23.61% 1-Year Est. Return
VCM
Veradace Capital Management Dallas, Texas $132M AUM
DFG
Dynamic Financial Group Cedar Falls, Iowa $132M AUM 11.02% 1-Year Est. Return

H&F Corporate Investors VIII's Q3 2025 Portfolio in Review

As of Q3 2025, H&F Corporate Investors VIII held 1 position worth $286M, up 18% from $243M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 0%. H&F Corporate Investors VIII opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • H&F Corporate Investors VIII's ten largest holdings make up 100% of its $286M portfolio in Q3 2025.
  • H&F Corporate Investors VIII opened 0 new positions and closed 0 in Q3 2025.
  • H&F Corporate Investors VIII's portfolio value rose 18% quarter-over-quarter to $286M.

Based on H&F Corporate Investors VIII's 13F filing for Q3 2025, filed 12 Nov 2025.